Global Napi Pharmaceuticals

Global Napi Pharmaceuticals

Sales markets: Western Europe | Eastern Europe | Middle East | Asia | Australia | North America | Africa | Central/South America

About us

***GLOBAL Pharma Group, Egypt ....Growth & Expansion***

was established in 1997, a private investment company for pharmaceutical formulations production in Egypt. In addition to its own branded generic formulations, GNP entered into license agreements with multinational pharmaceutical companies; of them, MSD, Sanofi, Pierre Fabre, Bayer Consumer Care, Boehringer Ingelheim, Elerte and others in addition to contract manufacturing with, Novartis/Sandoz, Pfizer and Stada.
 More than 100 GNP generic brands are available in tablet, capsule, solution, syrup, ointment, cream, gel, and suppository forms in Egypt and in other countries such as Yemen, Sudan, Tanzania, Uganda, Libya and Kenya and in 12 CIS countries. GNP was inspected and GMP approved site by Romanian authorities for PIC/S.  

* Global Pharmaceutical Industries (GPI)
It is a state of the art production site for sterile ampoules and vials in both solutions and lyophilized forms started production in August 2011. In addition to GPI branded generics, contract manufacturing agreements were established with Pfizer and Ranbaxy and their products are already in the market. GPI was inspected and GMP approved site by Romanian authorities for PIC/S. 

* Global Advanced Pharmaceuticals (GAP) is an emerging mega project in Egypt, composed of 6 modules for production of different pharmaceutical forms, Soft Gelatin Capsules, Ophthalmic Preparations, Intravenous Fluids, and Oncology Products in addition to Solids and Liquids. Production is expected to be in the first quarter 2017.  Partners are invited to participate in such project with any proposed scenario of business style.

 * Shamla Pharmaceutical Industries
is a collaborative project in Saudi Arabia, for production of pharmaceutical products which is under construction and expected to be ready for production by the first quarter 2017.

In 2015, two new collaborative projects were added to the group profile in the African region, * Trinity Pharma in Ethiopia and * Wadina in Sudan for pharmaceuticals production. The two projects are in the early stages of construction.

we are the owner of Ramco company import  and export ...API and finished formulation
we are the owner ofRamco distribution company ....2nd pharmaceutical distributor in EGYPT market

Visit us at : Booth No.90D10 ,24 - 26 October 2017 Messe Frankfurt, Germany
For more details, visit

contact mail :

Read more
Global Napi Pharmaceuticals

Contact information




View all contact information